Ken Griffin Kazia Therapeutics LTD Transaction History

Citadel Advisors LLC

  • $505 Billion
  • Q3 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Kazia Therapeutics LTD stock. As of the latest transaction made, Citadel Advisors LLC holds 78,800 shares of KZIA stock, worth $456,252. This represents 0.0% of its overall portfolio holdings.

Number of Shares
78,800
Previous 24,000 228.33%
Holding current value
$456,252
Previous $5,000 560.0%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$0.19 - $1.24 $10,622 - $69,328
55,910 Added 1224.49%
60,476 $26,000
Q2 2024

Aug 14, 2024
BUY
$0.2 - $0.46 $913 - $2,100
4,566 New
4,566 $1,000
Q4 2023

Feb 14, 2024
BUY
$0.39 - $0.99 $4,995 - $12,680
12,809 New
12,809 $5,000
Q2 2022

Aug 15, 2022
BUY
$4.1 - $8.38 $21,254 - $43,441
5,184 Added 29.48%
22,769 $95,000
Q3 2021

Nov 15, 2021
BUY
$8.65 - $11.64 $41,580 - $55,953
4,807 Added 37.62%
17,585 $202,000
Q2 2021

Aug 16, 2021
BUY
$9.1 - $14.71 $116,279 - $187,964
12,778 New
12,778 $125,000
Q4 2019

Feb 14, 2020
SELL
$2.84 - $7.4 $36,360 - $94,742
-12,803 Closed
0 $0
Q3 2019

Nov 14, 2019
SELL
$2.33 - $3.83 $17,871 - $29,376
-7,670 Reduced 37.46%
12,803 $48,000
Q2 2019

Aug 14, 2019
BUY
$2.31 - $3.58 $47,292 - $73,293
20,473 New
20,473 $49,000

Others Institutions Holding KZIA

# of Institutions
21
Shares Held
2.13M
Call Options Held
93.2K
Put Options Held
0
View Full List

About KAZIA THERAPEUTICS LTD

KZIA Quotes by TradingView
  • Ticker KZIA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,111,300
  • Market Cap $87.5M
  • Description
  • Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs. Its lead development candidate is Paxalisib, a small molecule, brain-penetrant inhibitor of the PI3K/Akt/mTor pathway, which is developed as a potential therapy for glioblastoma. It is also developing EVT801, an investigational new drug for various...
More about KZIA
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email